Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

AHA, 10 other patient groups release statement on proposed changes to ACA

The American Heart Association (AHA) and 10 other patient groups released a position statement on March 6 outlining priorities that Congress should consider when making changes to the Affordable Care Act (ACA).

Ascension Medical Group names former Cleveland Clinic executive its new president

Joseph Caccione, a cardiologist and Cleveland Clinic executive, has been named president of Ascension Medical Group.

Authorities charge New York cardiologist in alleged 12-year, $50 million fraud scheme

A cardiologist based in New York and five other people were indicted on March 1 for their part in an alleged 12-year scheme to defraud Medicaid, Medicare and private health insurance companies out of more than $50 million.

Thumbnail

ICU admissions for heart failure, acute MI may increase costs, not improve 30-day mortality

Medicare fee-for-service beneficiaries with an exacerbation of heart failure or acute MI who were admitted to the intensive care unit (ICU) had similar 30-day mortality rates compared with those who were not admitted to the ICU, according to a retrospective cohort study.

Cardiac resynchronization therapy may be cost effective in patients with mild heart failure

An analysis of a randomized trial found that cardiac resynchronization therapy (CRT) was cost effective compared with optimal medical therapy in patients with mild heart failure.

Cardiologist in New Mexico pleads guilty to fraud charge, sentenced to two years

Roy G. Heilbron, a cardiologist in New Mexico, pleaded guilty to a charge of healthcare fraud on Feb. 17 and admitted he overcharged private insurers and Medicare.

Medtronic’s shares increase after posting quarterly revenue growth

For the third quarter of fiscal year 2017, Medtronic’s revenue increased 5 percent of $7.283 billion, GAAP net income decreased 25 percent to $821 million and diluted earnings declined 23 percent to $1.12 per share compared with the same time period a year ago.

LVADs may not be cost effective in Medicare beneficiaries

Medicare beneficiaries with heart failure who were implanted with left ventricular assist devices (LVADs) had a significantly increase in lifetime costs compared with those treated with medical management, according to a cost-effectiveness model.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.